| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.07 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.082 | 0.08 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |